NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India
  • Home/
  • News/
  • DRDO Develops Antibody Test Kit DIPCOVAN For Early Detection Of COVID-19

News

DRDO Develops Antibody Test Kit DIPCOVAN For Early Detection Of COVID-19

DIPCOVAN antibody testing kit for detection of COVID-19 has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Private Limited

DRDO Develops Antibody Test Kit DIPCOVAN For Early Detection Of COVID-19
Highlights
  • The kit has been tested by on over 1,000 patient's samples
  • The kit has a shelf life of 18 months
  • It is expected to be available at about Rs. 75 per test

New Delhi: The Defence Research and Development Organisation (DRDO) has developed an antibody test kit for the early screening of COVID. DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd. According to DRDO, the kit can detect spike as well as nucleocapsid (S and N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent.

Also Read: Expert Answers Questions On COVID-19 Vaccination And Treatment

It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi. DRDO said three batches of the product were validated for the last one year. The antibody detection kit is approved by the Indian Council of Medical Research (ICMR) in April 2021. In May 2021, the product received regulatory approval from the Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare to manufacture for sale and distribution.

According to DRDO, DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turn-around time as it requires only 75 minutes to conduct the test without any cross-reactivity with other diseases.

The kit has a shelf life of 18 months. Vanguard Diagnostics Pvt. Ltd is expected to launch the product commercially by the first week of June 2021. Readily available stock at the time of launch will be 100 kits (approximately 10,000 tests) with a production capacity of 500 kits/month after the launch.

It is expected to be available at about Rs. 75 per test. The kit is believed to be very useful for understanding COVID-19 epidemiology and assessing an individual’s previous SARS-CoV-2 exposure. Earlier this week, DRDO launched the anti-COVID drug 2-deoxy-D-glucose (2-DG). It has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy’s Laboratories.

Also Read: COVID-19 Pandemic: ‘Black Fungus A New Challenge’, Says PM Modi While Interacting With Frontline Workers From Varanasi

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

[corona_data_new]

Highlights: Banega Swasth India Launches Season 10

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पढ़ें

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.